Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xinghe Wang

Showing results (91-100 of 94) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 94 results.
Antimicrobial Agents and Chemotherapy|September 7, 2021
Safety, Tolerability, Pharmacokinetics, and Immunogenicity of a Monoclonal Antibody (SCTA01) Targeting SARS-CoV-2 in Healthy Adults: a Randomized, Double-Blind, Placebo-Controlled, Phase I StudyYinjuan Li, Lu Qi, Haihong Bai, et al.
Frontiers in Oncology|January 6, 2023
A multicenter randomized trials to compare the bioequivalence and safety of a generic doxorubicin hydrochloride liposome injection with Caelyx <sup>®</sup> in advanced breast cancerYinjuan Li, Lu Qi, Yu Wang, et al.
British Journal of Pharmacology|October 5, 2024
The first in-human study to evaluate the antiplatelet properties of the clopidogrel conjugate DT-678 in acute coronary syndrome patients and healthy volunteersZhihao Liu, Shengcong Liu, Yanjun Gong, et al.
BMJ (Clinical Research Ed.)|May 13, 2026
Prophylactic tranexamic acid for the prevention of postpartum haemorrhage in women with placenta praevia: multicentre, double blind, randomised, placebo controlled, phase 3 trialLizi Zhang, Shilei Bi, Lian Chen, et al.
Pageof 10

Showing results (91-100 of 94) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 94 results.
Antimicrobial Agents and Chemotherapy|September 7, 2021
Safety, Tolerability, Pharmacokinetics, and Immunogenicity of a Monoclonal Antibody (SCTA01) Targeting SARS-CoV-2 in Healthy Adults: a Randomized, Double-Blind, Placebo-Controlled, Phase I StudyYinjuan Li, Lu Qi, Haihong Bai, et al.
Frontiers in Oncology|January 6, 2023
A multicenter randomized trials to compare the bioequivalence and safety of a generic doxorubicin hydrochloride liposome injection with Caelyx <sup>®</sup> in advanced breast cancerYinjuan Li, Lu Qi, Yu Wang, et al.
British Journal of Pharmacology|October 5, 2024
The first in-human study to evaluate the antiplatelet properties of the clopidogrel conjugate DT-678 in acute coronary syndrome patients and healthy volunteersZhihao Liu, Shengcong Liu, Yanjun Gong, et al.
BMJ (Clinical Research Ed.)|May 13, 2026
Prophylactic tranexamic acid for the prevention of postpartum haemorrhage in women with placenta praevia: multicentre, double blind, randomised, placebo controlled, phase 3 trialLizi Zhang, Shilei Bi, Lian Chen, et al.
Pageof 10